Literature DB >> 15621483

Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation.

Mathias H Wilhelmi1, Rainer G Leyh, Michaela Wilhelmi, Axel Haverich.   

Abstract

OBJECTIVE: In recent years many data emphasized, that inflammatory reactions seem to be involved in the pathogenesis of ischemic (ICM) and congestive (CCM) heart disease. Since, it is well known that endothelial adhesion molecules play a pivotal role in the initiation and maintenance of inflammatory reactions we therefore, evaluated the endothelial expression of a wide variety of different adhesion molecules in hearts suffering from ICM and CCM.
METHODS: Tissue samples from coronary arteries, and left and right ventricle myocardium originating form heart with ICM and CCM were evaluated. Tissue samples from healthy human donor hearts, which were not transplanted, served as controls. Evaluated adhesion molecule expression: selectin-family ELAM-1, CD62, immunoglobulin-supergene-family PECAM-1, ICAM-1, VCAM-1, integrin-family VLA-1,-2,-3,-4,-5, and -6, complementary-adhesion-molecules CD34, CD44 and the von-Willebrand-factor (vWF).
RESULTS: While endocardial surfaces and coronary arteries revealed only little differences when comparing tissue samples originating from healthy donor hearts and those suffering from ICM and CCM, significant differences were found within the myocardial microvasculature. Both kinds of diseased hearts showed stronger expressions for CD62, ELAM-1, ICAM-1 and VCAM-1 (only CCM) than controls. More and above, integrin molecules showed differential expressions too. Whereas, VLA-1 showed stronger expressions in diseased hearts, VLA-3,-5, and -6 were expressed much weaker in those hearts. Complementary adhesion molecules (CD34/CD44) did not show significant differences and the vWF was not found in any sample.
CONCLUSIONS: Inflammatory reactions play a pivotal role in the propagation and maintenance of both these cardiac detoriating diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621483     DOI: 10.1016/j.ejcts.2004.09.027

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy.

Authors:  Anne-Cecile Huby; Uzmee Mendsaikhan; Ken Takagi; Ruben Martherus; Janaka Wansapura; Nan Gong; Hanna Osinska; Jeanne F James; Kristen Kramer; Kazuyoshi Saito; Jeffrey Robbins; Zaza Khuchua; Jeffrey A Towbin; Enkhsaikhan Purevjav
Journal:  J Am Coll Cardiol       Date:  2014-12-30       Impact factor: 24.094

2.  Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease.

Authors:  Kanrawee Sungprem; Apichai Khongphatthanayothin; Patchara Kiettisanpipop; Pairoj Chotivitayatarakorn; Yong Poovorawan; Pornthep Lertsapcharoen
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

3.  Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium.

Authors:  Qing Deng; Bo Hu; Sheng Cao; Hong-Ning Song; Jin-Ling Chen; Qing Zhou
Journal:  Int J Mol Med       Date:  2015-05-28       Impact factor: 4.101

4.  Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy.

Authors:  Rui Xi; Qin Fan; Xiaoxiang Yan; Hang Zhang; Hongyang Xie; Gang Gu; Yan Xu; Fang Wang; Rong Tao
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

5.  Circulating Biomarkers of Cell Adhesion Predict Clinical Outcome in Patients with Chronic Heart Failure.

Authors:  Elke Bouwens; Victor J van den Berg; K Martijn Akkerhuis; Sara J Baart; Kadir Caliskan; Jasper J Brugts; Henk Mouthaan; Jan van Ramshorst; Tjeerd Germans; Victor A W M Umans; Eric Boersma; Isabella Kardys
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

6.  Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.

Authors:  Chenggang Fang; Zhan Lv; Zhimin Yu; Kexin Wang; Chengkai Xu; Yixuan Li; Yanggan Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-07-18       Impact factor: 2.174

7.  Hyaluronan and collagen in human hypertrophic cardiomyopathy: a morphological analysis.

Authors:  Martin Hellström; Anna Engström-Laurent; Stellan Mörner; Bengt Johansson
Journal:  Cardiol Res Pract       Date:  2012-07-26       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.